Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of 4-Demethyl-4-cholesteryloxycarbonylpenclome in Patients With Brain Tumors (DM-CHOC-PEN)

This study has been completed.
Sponsor:
Collaborators:
Tulane University Medical Center, New Orleans, LA
Icahn School of Medicine at Mount Sinai
Detroit Clinical Research Center, Farmington Hills, Lansing and Owasso, MI
National Cancer Institute (NCI)
Ochsner Medical Center, New Orleans, LA
The University of Texas Health Science Center, Houston
Information provided by (Responsible Party):
DEKK-TEC, Inc.
ClinicalTrials.gov Identifier:
NCT02038218
First received: January 15, 2014
Last updated: June 21, 2016
Last verified: June 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2016
  Primary Completion Date: May 2016 (Final data collection date for primary outcome measure)